Six protein array assay schemes and three different labels (Au, carbon, enzyme) were evaluated to identify the most sensitive colorimetric assay scheme to be exploited in an on-chip immunoassay for IL8, DCN, and VEGF, three protein markers that have been previously demonstrated to be important for the detection of bladder cancer recurrence. The gene discussed is DCN; the disease is urinary bladder cancer.